Photodynamic anti-gram-positive bacterial activity of pharmaceutical-grade rose bengal
Abstract
This invention contemplates combined use of a rose bengal (RB) derivative with irradiation of bacteria with light to treat and kill the irradiated bacteria. In one aspect, Gram-positive bacteria are treated in a method in which the bacteria are contacted with an aqueous pharmaceutical composition containing a rose bengal (RB) compound of Formula I, discussed within, dissolved or dispersed therein at about 0.2 to about 3.1 µg/mL. Those contacted bacteria are contacted with light of the wavelength about 500 nm to about 600 nm for a time period of about 1 to about 10 minutes to provide a light dose of about 0.7 to about 7.2 J/cm2. A similar method is contemplated for treating Gram-negative bacteria that are one or more of Burkholderia, Salmonella, and Proteus using an aqueous pharmaceutical composition containing about 2 to about 15 µM concentration of the RB compound.
Claims
exact text as granted — not AI-modified1 . A method of treating a Gram-positive bacteria that comprises the steps of:
a) contacting said Gram-positive bacteria with an aqueous pharmaceutical composition containing a rose bengal (RB) compound of Formula I, below, dissolved or dispersed therein at a concentration of about 0.2 to about 3.1 µg/mL; and b) irradiating those contacted bacteria with light of the wavelength about 500 nm to about 600 nm for a time period of about 1 to about 10 minutes to provide a light dose of about 0.7 to about 7.2 J/cm 2 wherein X is oxygen or nitrogen, “n” is zero or 1 such that when X is oxygen, n is zero and R 2 is absent, and when X is nitrogen, n is 1 and R 2 is present; when X is oxygen, R 1 is selected from the group consisting of hydrogen (H), M + that is a pharmaceutically acceptable cation, C 1 -C 4 alkyl, and an aromatic ring as defined herein after; when X is nitrogen, R 1 and R 2 are the same or different and are selected from the group consisting of hydrogen, C 1 -C 4 alkyl, or together with amido nitrogen atom form a 5- or 6-membered ring, and an aromatic ring as defined herein after; wherein said aromatic ring is a single ring containing 5- or 6-members, or a 5,6- or 6,6-fused aromatic ring system, said aromatic ring or ring system containing 0, 1 or 2 hetero ring atoms that are independently nitrogen, oxygen or sulfur.
2 . The method according to claim 1 , wherein said RB compound is rose bengal disodium.
3 . The method according to claim 1 , wherein said Gram-positive bacteria are one or more of drug-susceptible and drug-resistant S. aureus , S. epidermis, E. faecalis and E. faecium .
4 . The method according to claim 1 , wherein said Gram-positive bacteria are one or more Bacillus subtilis , Bacillus cereus , and Streptococcus salivarius .
5 . The method according to claim 1 , wherein said Gram-positive bacteria are present within or on mammalian cells when contacted.
6 . The method according to claim 1 , wherein said Gram-positive bacteria are present as a biofilm.
7 . The method according to claim 1 , wherein said Gram-positive bacteria are irradiated for a time period of about 2 to about 5 minutes to provide a light dose of about 1.4 to about 3.6 J/cm 2 .
8 . The method according to claim 1 , wherein said aromatic ring substituent is selected from one or more of the group consisting of one or more of
where
providing an ester or a monosubstituted amine, respectively.
9 . A method of treating a Gram-negative bacteria selected from the group consisting of one or more of Burkholderia , Salmonella , and Proteus that comprises the steps of:
a) contacting said Gram-positive bacteria with an aqueous pharmaceutical composition containing a rose bengal (RB) compound of Formula I, below, dissolved or dispersed therein at a concentration of about 2 to about 15 µM; and
b) irradiating those contacted bacteria with light of the wavelength about 500 nm to about 600 nm for a time period of about 1 to about 10 minutes to provide a light dose of about 0.7 to about 7.2 J/cm 2
wherein X is oxygen or nitrogen, “n” is zero or 1 such that when X is oxygen, n is zero and R 2 is absent, and when X is nitrogen, n is 1 and R 2 is present;
when X is oxygen, R 1 is selected from the group consisting of hydrogen (H), M + that is a pharmaceutically acceptable cation, C 1 -C 4 alkyl, and an aromatic ring as defined herein after;
when X is nitrogen, R 1 and R 2 are the same or different and are selected from the group consisting of hydrogen, C 1 -C 4 alkyl, or together with amido nitrogen atom form a 5- or 6-membered ring, and an aromatic ring as defined herein after;
wherein said aromatic ring is a single ring containing 5- or 6-members, or a 5,6- or 6,6-fused aromatic ring system, said aromatic ring or ring system containing 0, 1 or 2 hetero ring atoms that are independently nitrogen, oxygen or sulfur.
10 . The method according to claim 9 , wherein said Gram-positive bacteria are present within or on mammalian cells when contacted.
11 . The method according to claim 9 , wherein said Gram-positive bacteria are irradiated for a time period of about 2 to about 5 minutes to provide a light dose of about 1.4 to about 3.6 J/cm 2 .Join the waitlist — get patent alerts
Track US2023233515A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.